WallStreetZenWallStreetZen

NASDAQ: VVOS
Vivos Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

VVOS past revenue growth

How has VVOS's revenue growth performed historically?
Company
-13.87%
Industry
9.39%
Market
17.61%
VVOS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VVOS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
VVOS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

VVOS earnings and revenue history

Current Revenue
$13.8M
Current Earnings
-$13.6M
Current Profit Margin
-98.4%

VVOS Return on Equity

Current Company
-568.6%
Current Industry
10.5%
Current Market
188%
VVOS's Return on Equity (-568.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when VVOS announces earnings.

VVOS Return on Assets

Current Company
-104.7%
Current Industry
5.3%
VVOS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VVOS Return on Capital Employed

Current Company
-394.74%
Current Industry
8.3%
VVOS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VVOS vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VVOS$13.80M-$12.96M-$13.58M+29.48%N/A
NURO$5.90M-$6.47M-$6.53M-18.18%N/A
HSCS$18.60k-$6.00M-$6.39M-14.04%N/A
OPGN$3.07M-$22.42M-$26.16M-0.69%N/A
AIMD$0.00-$8.75M-$13.77M-100.00%N/A
View Top Medical Device Stocks

VVOS earnings dates

Next earnings date
Jun 6, 2024

Vivos Therapeutics Earnings & Revenue FAQ

What were VVOS's earnings last quarter?

On Invalid Date, Vivos Therapeutics (NASDAQ: VVOS) reported Q4 2023 earnings per share (EPS) of -$3.05, up 39% year over year. Total Vivos Therapeutics earnings for the quarter were -$4.26 million. In the same quarter last year, Vivos Therapeutics's earnings per share (EPS) was -$5.00.

If you're new to stock investing, here's how to buy Vivos Therapeutics stock.

What was VVOS's earnings growth in the past year?

As of Q2 2024, Vivos Therapeutics's earnings has grown year over year. Vivos Therapeutics's earnings in the past year totalled -$13.58 million.

What is VVOS's earnings date?

Vivos Therapeutics's earnings date is Invalid Date. Add VVOS to your watchlist to be reminded of VVOS's next earnings announcement.

What was VVOS's revenue last quarter?

On Invalid Date, Vivos Therapeutics (NASDAQ: VVOS) reported Q4 2023 revenue of $3.25 million up 17.77% year over year. In the same quarter last year, Vivos Therapeutics's revenue was $3.95 million.

What was VVOS's revenue growth in the past year?

As of Q2 2024, Vivos Therapeutics's revenue has grown -13.87% year over year. This is 23.26 percentage points lower than the US Medical Devices industry revenue growth rate of 9.39%. Vivos Therapeutics's revenue in the past year totalled $13.80 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.